The life science industry integrates expertise from biology, chemistry, pharmacy, mechanical automation, materials, and other fields to provide bioprocess solutions, laboratory products and services, as well as pharmaceutical health products and services. Bioprocess solutions mainly focus on the manufacturing end, offering instrumentation and consumables for the commercialization stage of biopharmaceuticals, covering all aspects of the biopharmaceutical process. Laboratory products and services primarily concentrate on the research end, providing instrumentation and consumables for biopharmaceutical companies, CROs and CDMO enterprises, academic research institutions, etc. Pharmaceutical separation and purification equipment, including liquid chromatographs, is widely used at various stages of drug research and development and production, playing an important role in the biopharmaceutical process. With the support of '14th Five-Year Plan' policies for the pharmaceutical economy, the increase in disposable income among residents, and the growth of an aging population and the number of chronic disease patients, China's pharmaceutical market is booming, maintaining a growth rate higher than the global market. Pharmaceutical separation and purification equipment is widely used in multiple aspects such as pharmaceutical research and development, production, and quality control. Driven by the growth of downstream market demand, it is expected to experience rapid growth. The future market prospects are broad. For this reason, based on research into this market, Frost & Sullivan (Frost & Sullivan) has released an independent research report titled 'Life Science Equipment Market'.
